PATENT CLAIM ANALYSIS

Application Number: 15820589
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-06
Patent Classification: ["514", "165000"]

Abstract:
The invention relates to the use of a composition comprising lysine acetylsalicylate for the production of a drug in a form suitable for intravitreal administration, for the treatment of diabetic retinopathy.

Claim (Index 10):
The composition according to  claim 9 , wherein the concentration of lysine acetylsalicylate is between 12 mg/ml of composition and 24 mg/ml of composition.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 90.0
- Lexical Diversity: 1.32
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15818089', '15043750', '10371850', '14212817', '10729475']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.790690889949222
- 35 USC 102 Novelty (BERT): 0.4923365103855494
- Combined Prediction Score: 0.7608554519928548
- Mean Citation Score: 207.419446
- Max Citation Score: 211.28287000000003
- Similarity Product: 148.10654126111868

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test